These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 38662954)
1. Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma. Zeng L; Xie L; Hu J; He C; Liu A; Lu X; Zhou W Cell Cycle; 2024 Mar; 23(5):537-554. PubMed ID: 38662954 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1. Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545 [TBL] [Abstract][Full Text] [Related]
3. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT. Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277 [TBL] [Abstract][Full Text] [Related]
4. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma. Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131 [TBL] [Abstract][Full Text] [Related]
5. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation. Yamamoto-Fukuda T; Akiyama N Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2. Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin mediating cyclosporine A induced epithelial-to-mesenchymal transition on rat renal tubular epithelial cells. Xu D; Chen X; Deng Z; Tan R; Liu C; Lu P; Zhang W; Gu M Cell Biol Int; 2014 Jan; 38(1):8-15. PubMed ID: 23788374 [TBL] [Abstract][Full Text] [Related]
8. Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear. Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Kakihana M; Shimano K; Terada N; Sakagami M Auris Nasus Larynx; 2004 Mar; 31(1):3-9. PubMed ID: 15041047 [TBL] [Abstract][Full Text] [Related]
9. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma. Liu W; Ren H; Ren J; Yin T; Hu B; Xie S; Dai Y; Wu W; Xiao Z; Yang X; Xie D Mediators Inflamm; 2013; 2013():651207. PubMed ID: 24311896 [TBL] [Abstract][Full Text] [Related]
10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
11. Osteopontin Promotes Invasion, Migration and Epithelial-Mesenchymal Transition of Human Endometrial Carcinoma Cell HEC-1A Through AKT and ERK1/2 Signaling. Li Y; Xie Y; Cui D; Ma Y; Sui L; Zhu C; Kong H; Kong Y Cell Physiol Biochem; 2015; 37(4):1503-12. PubMed ID: 26509489 [TBL] [Abstract][Full Text] [Related]
12. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling. Wu DM; Zhang T; Liu YB; Deng SH; Han R; Liu T; Li J; Xu Y Cell Death Dis; 2019 Apr; 10(5):349. PubMed ID: 31024010 [TBL] [Abstract][Full Text] [Related]
13. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
15. Akt and Notch pathways mediate polyhexamethylene guanidine phosphate-induced epithelial-mesenchymal transition via ZEB2. Jeong MH; Kim HR; Park YJ; Chung KH Toxicol Appl Pharmacol; 2019 Oct; 380():114691. PubMed ID: 31348943 [TBL] [Abstract][Full Text] [Related]
16. Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model. Bhattacharya SD; Mi Z; Kim VM; Guo H; Talbot LJ; Kuo PC Ann Surg; 2012 Feb; 255(2):319-25. PubMed ID: 22241292 [TBL] [Abstract][Full Text] [Related]
17. Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells. Ho NT; Lin SW; Lee YR; Tzeng CR; Kao SH Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499654 [TBL] [Abstract][Full Text] [Related]
18. MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway. Liu D; Ma X Int J Med Sci; 2021; 18(14):3224-3235. PubMed ID: 34400892 [TBL] [Abstract][Full Text] [Related]
19. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222 [TBL] [Abstract][Full Text] [Related]
20. [ Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]